Skip to main content

Davion Healthcare PLC

DAVI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0002039072

In the last 90 days, Davion Healthcare PLC insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Key figures

Market capADS ratio not in SEC data
–
Insider buysLast 90 days, $36.3K in total
2
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026
0
13F valueReported value at the end of Q3 2026
$0
Superinvestors holdingAt the end of Q3 2026
0

Price chart

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
617.7K
Shares sold short
Change
+617.7K
+100.0% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding DAVI, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding DAVI at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Davion Healthcare PLC insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)10:44 AM ETNov 171 dayKing Susan MDirectorPPurchase+10.0K$0.98+$9.80K+200.0%15.0K afterAmended
Nov 17, 2026 (view filing)8:38 AM ETNov 161 daySluyters JulianDirectorPPurchase+25.0K$1.06+$26.5K+500.0%30.0K after

Top 10 13F holders, Q3 2026

View all: Top 10 13F holders, Q3 2026

The largest institutional positions in Davion Healthcare PLC at the end of Q3 2026; share changes are against Q2 2026.

No institution reported holding DAVI in 13F filings for Q3 2026.

Holders of 5% or more of DAVI

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Davion Healthcare PLC.

Largest holders of DAVI from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Kaye Jack Harry13D/A41.08%10.3M shares–Aug 11, 20261 filingAug 11, 2026SEC
Kaye Jack Harry13D20.64%5.16M sharesNewApr 17, 20261 filingApr 17, 2026SEC